During the “Mitral Valve” session (on the first day of the SOLACI-SOCIME 2022 Congress), Dr. Ignacio Amat Santos (SPA) delivered a great talk on transcatheter mitral valve replacement (TMVR). During his presentation, he discussed different scenarios for transcatheter replacement: mitral valve-in-vale, mitral valve-in-ring, mitral valve in MAC, and new devices for non-calcified native valves. When…
SOLACI CACI 2017 | Perspectives of Transcatheter mitral valve replacement (TMVR): early data
Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. José Luis Navia, entitled “Perspectives of Transcatheter mitral valve replacement (TMVR): early data”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Diastolic Dysfunction: Shall We Begin to Assess It?
Courtesy of Dr. Carlos Fava. The association between diastolic dysfunction (DD) and aortic insufficiency (AI) after transcatheter aortic valve replacement (TAVR) has not been studied yet, but the presence of aortic regurgitation has proved to be associated with worse outcomes. A total of 144 out of 195 patients who underwent TAVR with balloon-expandable SAPIENS or SAPIENS XT…
Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: A Global Study
Symptomatic mitral regurgitation is associated with high morbidity and mortality that can be alleviated partly by surgical mitral valve replacement. However, many patients do not undergo surgery. Transcatheter mitral valve replacement is an appealing option for this selected patient group. This study aimed to examine the effectiveness and safety of transcatheter mitral valve replacement…